Tempus: Ned Sharpless

Tempus said that Norman "Ned" Sharpless will serve as a senior strategic advisor to the company. Sharpless was most recently director of the National Cancer Institute, part of the National Institutes of Health, a position he held from 2017 to 2022. He also served as acting commissioner for the US Food and Drug Administration in 2019 before return to NCI. Prior to his time at NCI, Sharpless was director of the University of North Carolina Lineberger Comprehensive Cancer Center. He received his MD from the UNC School of Medicine, and completed his clinical training at Massachusetts General Hospital and the Dana-Farber Cancer Institute, both of Harvard Medical School.